tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Island Pharmaceuticals Issues New Shares Following Option Exercise

Story Highlights
Island Pharmaceuticals Issues New Shares Following Option Exercise

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from Island Pharmaceuticals Ltd ( (AU:ILA) ).

Island Pharmaceuticals Limited has issued 11,142,061 fully paid ordinary shares following the exercise of unlisted options at an issue price of $0.07 per share. This issuance was conducted without disclosure to investors under Part 6D.2 of the Corporations Act, and the company confirms compliance with relevant provisions of the Act. The announcement reflects the company’s ongoing operational activities and adherence to regulatory standards.

More about Island Pharmaceuticals Ltd

Island Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange under the ticker ASX: ILA.

Average Trading Volume: 590,898

Technical Sentiment Signal: Buy

Current Market Cap: A$37.77M

For an in-depth examination of ILA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1